Search - tctmd.com

Displaying 341 - 360 of 815

Sort: Relevancy | Date

News Conference News TCT 2019

GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients?

Todd Neale

September 30, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Shelley Wood

September 29, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

Shelley Wood

September 29, 2019

Presentation TCT 2019

STOPDAPT, SMART-CHOICE, and TWILIGHT: Will These Trials Change Your Clinical Practice?

Presenter: Aditya Kapoor

September 28, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

CIN Prevention II: Clinical Trials Summary of Completed and Ongoing Studies

Presentation TCT 2019

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Presenter: Somjot Brar

September 28, 2019

Presentation TCT 2019

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

Presenter: Robert Bonow

September 28, 2019

Presentation TCT 2019

When Trials Disagree: The COAPT/MITRA-FR Case Study

Presenter: Milton Packer

September 28, 2019

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

Presentation TCT 2019

Update on Target BP Trials Program (Chemical Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Felix Mahfoud

September 28, 2019

Presentation TCT 2019

Update on RADIANCE Trials Program (Ultra-Sound Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Ajay Kirtane

September 28, 2019

Presentation TCT 2019

Update on SPRYRAL Trials Program (Radiofrequency Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Michael Boehm

September 28, 2019

Presentation TCT 2019

Death Following DCB Use – Not! Clinical Data from Coronary Trials

Presenter: Bruno Scheller

September 28, 2019

Presentation TCT 2019

Intravenous Platelet Inhibition for PCI: Drug Description and Clinical Outcomes From Randomized Trials and Registries

Presenter: Matthew Price

September 27, 2019

News Conference News TCT 2019

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Michael O'Riordan

September 27, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

Presentation TCT 2019

FFR-CT State of the Art Clinical Study Evidence and Ongoing/Planned Trials

Presenter: Manesh Patel

September 27, 2019

Advertisement

GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients?

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

STOPDAPT, SMART-CHOICE, and TWILIGHT: Will These Trials Change Your Clinical Practice?

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

When Trials Disagree: The COAPT/MITRA-FR Case Study

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Update on Target BP Trials Program (Chemical Renal Denervation): Lessons Learned, Ongoing Efforts

Update on RADIANCE Trials Program (Ultra-Sound Renal Denervation): Lessons Learned, Ongoing Efforts

Update on SPRYRAL Trials Program (Radiofrequency Renal Denervation): Lessons Learned, Ongoing Efforts

Death Following DCB Use – Not! Clinical Data from Coronary Trials

Intravenous Platelet Inhibition for PCI: Drug Description and Clinical Outcomes From Randomized Trials and Registries

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Portico Noninferior to Commercial TAVR Valves in IDE Study

FFR-CT State of the Art Clinical Study Evidence and Ongoing/Planned Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content